Acute urticaria as the initial presentation of COVID-19 in a pediatric patient

The authors report the case of a 16-year-old boy with pre-B cell acute lymphocytic leukemia diagnosed 2 weeks earlier. On workup for diffuse headaches he was found to have 10-mm bilateral subdural hygromas with compression of the underlying gyri. He was followed clinically, and 4 days after his initial presentation he underwent MRI studies of the brain, which showed complete resolution of the subdural fluid collections. No change in management was noted during these 4 days. This case is the first known instance of rapid, spontaneously disappearing bilateral subdural hygromas in a pediatric patient.

Download Full-text

Long-term cure of high-grade spinal cord glioma in a pediatric patient who underwent cordectomy

Journal of Neurosurgery Spine ◽

10.3171/2015.7.spine15656 ◽

2015 ◽

Vol 23 (5) ◽

pp. 635-641 ◽

Cited By ~ 2

Author(s):

R. Webster Crowley ◽

Rebecca M. Burke ◽

M. Beatriz S. Lopes ◽

D. Kojo Hamilton ◽

John A. Jane

Keyword(s):

Spinal Cord ◽

Pediatric Patient ◽

Poor Prognosis ◽

Pediatric Population ◽

Initial Presentation ◽

Treatment Modalities ◽

High Grade ◽

Spinal Cord Glioma ◽

Number Of Treatment

High-grade spinal cord gliomas are rare and carry a poor prognosis. A number of treatment modalities exist for spinal cord gliomas, but no consensus exists regarding their management. Cordectomy represents a possible option for treating these lesions; however, few cases have been reported in adults, and none have been reported in the pediatric population. The authors describe the use of cordectomy for the treatment of a high-grade spinal glioma in a 9-year-old boy who remains cancer free 14 years following his initial presentation.

Download Full-text

Use of Recombinant Factor VIIa in a Pediatric Patient With Initial Presentation of Refractory Acute Immune Thrombocytopenic Purpura and Severe Bleeding

The Journal of Pediatric Pharmacology and Therapeutics ◽

10.5863/1551-6776-17.3.274 ◽

2012 ◽

Vol 17 (3) ◽

pp. 274-280

Author(s):

Reut Gurion ◽

Anita Siu ◽

Aaron R. Weiss ◽

Margaret Masterson

Keyword(s):

Pediatric Patient ◽

Immune Thrombocytopenic Purpura ◽

Recombinant Factor Viia ◽

Factor Viia ◽

Initial Presentation ◽

High Dose ◽

Severe Bleeding ◽

Thrombocytopenic Purpura ◽

Intravenous Immunoglobulin G ◽

Acute Itp

Severe bleeding in acute immune thrombocytopenic purpura (ITP) is rare but can cause significant complications to the patient. Here we report the case of a pediatric patient with acute ITP and hematuria refractory to anti-D immune globulin, high dose intravenous immunoglobulin G, and high dose steroids. Her hematuria was successfully treated with recombinant factor VIIa (rFVIIa). While further investigation on the use of rFVIIa in ITP is warranted, this case report contributes to the pediatric literature for its use during the course of an initial presentation of ITP with hemorrhagic complications.

Download Full-text